Literature DB >> 8785135

Perioperative changes in alpha 1-acid glycoprotein concentrations in infants undergoing major surgery.

P D Booker1, C Taylor, G Saba.   

Abstract

alpha 1-Acid glycoprotein (AAG) is an acute phase protein that is responsible for binding basic drugs such as bupivacaine. In order to determine how AAG concentrations change in response to surgical stress, arterial blood samples were obtained from 50 infants undergoing major surgery, at induction of anaesthesia and daily for the next 7 days. AAG concentrations were measured using a rate nephelometric technique. The overall mean preoperative AAG concentration was 0.38 (SD 0.16) mg ml-1, although concentrations were significantly greater in infants undergoing urgent surgery compared with those undergoing elective surgery (P = 0.02). There were no significant correlations between gestational or postnatal age and preoperative AAG concentration. Mean AAG concentrations increased to 0.76 (0.18) mg ml-1 by day 4 after surgery and stayed at that concentration thereafter. Infants with preoperative AAG concentrations < 0.38 mg ml-1 showed a greater percentage increase in postoperative AAG concentrations than did infants with preoperative AAG concentrations > 0.38 mg ml-1 (P = 0.001). We conclude that preoperative measurement of AAG may identify those infants most at risk of drug toxicity in the early postoperative period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785135     DOI: 10.1093/bja/76.3.365

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  14 in total

Review 1.  Population clinical pharmacology of children: modelling covariate effects.

Authors:  Brian J Anderson; Karel Allegaert; Nicholas H G Holford
Journal:  Eur J Pediatr       Date:  2006-06-29       Impact factor: 3.183

2.  A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Authors:  Esther Encinas; Rosario Calvo; John C Lukas; Valvanera Vozmediano; Monica Rodriguez; Elena Suarez
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

Review 3.  Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: therapeutic implications.

Authors:  Jean-Xavier Mazoit
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection.

Authors:  Edouard Ollier; Fabrice Heritier; Caroline Bonnet; Sophie Hodin; Brigitte Beauchesne; Serge Molliex; Xavier Delavenne
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

Review 5.  Benefit and risks of local anesthetics in infants and children.

Authors:  Joel B Gunter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Adverse effects of regional anaesthesia in children.

Authors:  B J Dalens; J X Mazoit
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

Review 7.  Pharmacokinetics of local anaesthetics in infants and children.

Authors:  Jean-Xavier Mazoit; Bernard J Dalens
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 8.  A Review of Regional Anesthesia in Infants.

Authors:  Karen R Boretsky
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

9.  A Novel Perioperative Multidose Methadone-Based Multimodal Analgesic Strategy in Children Achieved Safe and Low Analgesic Blood Methadone Levels Enabling Opioid-Sparing Sustained Analgesia With Minimal Adverse Effects.

Authors:  Senthilkumar Sadhasivam; Blessed W Aruldhas; Senthil Packiasabapathy; Brian R Overholser; Pengyue Zhang; Yong Zang; Janelle S Renschler; Ryan E Fitzgerald; Sara K Quinney
Journal:  Anesth Analg       Date:  2021-08-01       Impact factor: 6.627

10.  Anaesthesia and the acute phase protein response in children undergoing circumcision.

Authors:  Unase Buyukkocak; Fatma Caglayan; Osman Caglayan; Murat Basar; Murat Cakmak; Ertan Batislam; Sevgi Ulusoy
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.